Hamburg Trumpets Potential Rewards Of Quality Improvement For Generic Industry
This article was originally published in The Pink Sheet Daily
FDA Commissioner takes a softer tone in repeating the message that quality must improve in the generics industry, saying the reward may manifest in inspection policy.
You may also be interested in...
Agency expects to provide $200,000 to $50 million on a wide range of research proposals to support regulatory science and innovation.
CDER’s Woodcock says the new database will drive risk-based inspection decisions.
“This is a shared responsibility. We have to have a shared sense of urgency,” Acting OGD director tells GPhA.